Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Healthy Volunteers)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04591717
What this trial is testing

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

Who this might be right for
COVID-19
ImmunityBio, Inc. 34
Early research (Phase 1)WithdrawnNCT05429385
What this trial is testing

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

Who this might be right for
COVID-19
Shanghai Henlius Biotech
Early research (Phase 1)WithdrawnNCT06274853
What this trial is testing

GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects

Who this might be right for
COVID-19
National Center for Advancing Translational Sciences (NCATS)
Large-scale testing (Phase 3)Study completedNCT04942405
What this trial is testing

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

Who this might be right for
Covid19
Health Institutes of Turkey 1,290
Not applicableUnknownNCT05673980
What this trial is testing

Oral Vitamin D2 for Prevention of COVID-19

Who this might be right for
Healthy Volunteers
Peking University Third Hospital 218
Early research (Phase 1)Study completedNCT04532294
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Who this might be right for
Covid19
BeiGene 18
Testing effectiveness (Phase 2)Study completedNCT04639466
What this trial is testing

A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection

Who this might be right for
COVID-19 Infection
GeoVax, Inc. 119
Testing effectiveness (Phase 2)UnknownNCT05439824
What this trial is testing

SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

Who this might be right for
SARS-CoV-2 Infection
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 450
Early research (Phase 1)Study completedNCT04468958
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants

Who this might be right for
COVID-19SARS-CoV2
SAb Biotherapeutics, Inc. 28
Not applicableStudy completedNCT04339790
What this trial is testing

Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers

Who this might be right for
Healthy VolunteerMood DisorderAnxiety Disorder+1 more
National Institute of Mental Health (NIMH) 3,655
Testing effectiveness (Phase 2)Study completedNCT05142514
What this trial is testing

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 629
Not applicableStudy completedNCT04865237
What this trial is testing

SARS-CoV-2 Human Challenge Characterisation Study

Who this might be right for
Covid19SARS-CoV InfectionCorona Virus Infection+2 more
Imperial College London 36
Not applicableStudy completedNCT05388201
What this trial is testing

Variation In Facial Morphology As A Determinant Of Face Covering Performance: FACEFIT

Who this might be right for
Healthy
University of North Carolina, Chapel Hill 100
Not applicableStudy completedNCT04740320
What this trial is testing

COVID-19 SARS-CoV-2 Screening Protocol

Who this might be right for
Covid19
Imperial College London 36
Early research (Phase 1)Study completedNCT04839042
What this trial is testing

A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers

Who this might be right for
Covid19
Moat Biotechnology Corporation 196
Early research (Phase 1)Study completedNCT04737486
What this trial is testing

A First-in-Human Study of AV-001 in Healthy Subjects

Who this might be right for
Covid19-associated ARDSCovid19ARDS
Vasomune Therapeutics, Inc. 48
Early research (Phase 1)UnknownNCT04480333
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831

Who this might be right for
Covid19Corona Virus InfectionSevere Acute Respiratory Syndrome+5 more
Biomed Industries, Inc. 45
Testing effectiveness (Phase 2)UnknownNCT05175950
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)

Who this might be right for
COVID-19 (Healthy Volunteers)
Korea University Guro Hospital 770
Early research (Phase 1)UnknownNCT04864548
What this trial is testing

COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study

Who this might be right for
Coronavirus
University of Oxford 132
Testing effectiveness (Phase 2)Study completedNCT04742738
What this trial is testing

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

Who this might be right for
COVID-19 (Healthy Volunteers)
SK Bioscience Co., Ltd. 260
Next Page